← 返回

子宫内膜癌 TIL(肿瘤浸润淋巴细胞)的免疫图谱单细胞分析

英文原题:Single-Cell Profiling of the Immune Atlas of Tumor-Infiltrating Lymphocytes in Endometrial Carcinoma.

查看英文原题

Single-Cell Profiling of the Immune Atlas of Tumor-Infiltrating Lymphocytes in Endometrial Carcinoma.

PubMed 2022/09/02(内容时间) Cancers (Basel) Q2 · IF 4.8(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

子宫内膜癌(EC)是一种高发病率的妇科恶性肿瘤;然而,关于EC中TIL(肿瘤浸润淋巴细胞)群体的深入研究尚缺乏。我们旨在通过单细胞RNA测序(scRNA-seq)、质谱流式和流式细胞术分析,绘制I型EC中TIL的免疫图谱。

我们发现自然杀伤(NK)细胞和CD8+ T淋巴细胞是EC患者TIL的主要组成部分。我们首次鉴定了三个转录上不同的NK细胞亚群,它们可能具有多样的抗肿瘤功能。

此外,CD103+细胞对CD8+ T细胞群体有显著贡献。CD103+ CD8+ T细胞的标志性基因表达表明该细胞亚群具有组织驻留、免疫记忆和耗竭特性,被定义为组织驻留记忆T细胞(T RM细胞)。

此外,基于scRNA-seq和质谱流式分析,我们首次鉴定了CD103+ CD8+ T细胞的内在异质性,这些细胞被认为具有不同的细胞毒性、细胞黏附和耗竭状态功能。

总体而言,发现了不同的NK细胞亚群,可能为未来的研究提供启示。CD103+ CD8+ T细胞群体可能是EC中的一个重要免疫治疗靶点,针对该细胞群体联合免疫抑制治疗可能提高EC免疫治疗的疗效。

展开英文摘要原文

Endometrial carcinoma (EC) is a gynecological malignancy with a high incidence; however, thorough studies on tumor-infiltrating lymphocyte (TIL) populations in EC are lacking.

We aimed to map the immune atlas of TILs in type I EC via single-cell RNA sequencing (scRNA-seq), mass cytometry and flow cytometry analysis.

We found that natural killer (NK) cells and CD8+ T lymphocytes were the major components of TILs in EC patients.

We first identified three transcriptionally distinct NK cell subsets, which are likely to possess diverse anti-tumor functions.

Additionally, CD103+ cells substantially contributed to the CD8+ T cell population. The signature gene expression of CD103+ CD8+ T cells indicated the tissue residency, immunological memory, and exhaustion properties of this cell subset, which were defined as tissue-resident memory T cells (T RM cells).

Moreover, based on scRNA-seq and mass cytometry analysis, we first identified the intrinsic heterogeneity of CD103+ CD8+ T cells that were thought to have a distinct cytotoxicity, cell adhesion and exhaustion status functions. Collectively, distinct subsets of NK cells were found and might shed light on future investigations. CD103+ CD8+ T cell population may be an important immunotherapeutic target in EC and targeting this cell population with combined immunosuppressive therapy might improve the efficacy of immunotherapy for EC.

论文信息

作者
Jiang F、Jiao Y、Yang K、Mao M、Yu M、Cao D、Xiang Y
单位
Department of Obstetrics and Gynaecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, National Clinical Research Centre for Obstetric & Gynaecologic Diseases, Beijing 100730, China.China
期刊
Cancers2022 Sep 2
原文标识
PubMed 36077846 · DOI 10.3390/cancers14174311